What's new
about our new
vegetarian capsules? 

Everything.

LEARN MORE

Scroll down

We’ve been supplying our customers with vegetarian capsules for many years.

But if you ask us what’s new about these ones, the short answer is: EVERYTHING.

They’re cleaner

Completely natural and free from animal products; with an independent ‘clean label’ certification - a world first. They contain no artificial colourants, are completely free of titanium dioxide, and are perfect for dietary supplements and other nutraceutical products.

They’re more targeted

We have a range of variants for different applications – from time-dependent and delayed release capsules that protect acid-sensitive drugs from gastric fluids, to others that cater for more complex and sensitive formulations. We can even collaborate on creating a purpose-made solution for your specific delivery needs.  

They can be customised

Our capsules are perfectly clear to show off your product, but you can also choose to colour them, and print on them (all completely naturally, of course) for additional brand appeal.

So, while our new vegetarian capsules aren’t the first we’ve ever made, they certainly are the best. Contact us to find out more. 

CLICK HERE

Go to article: Home | Getting the skinny on generics labellingGo to article: In this issueGo to article: ContentsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: The Solubility companyGo to article: The Solubility Company Insight Go to article: CommentGo to article: Market access of orphan designated therapies at riskGo to article: Lodo Therapeutics’ AI-driven natural drug discovery platformGo to article: Concert Pharmaceuticals discontinues schizophrenia drug after trial failureGo to article: Medical cannabis in Europe: a compelling opportunityGo to article: Exploring the pharma deals outlook in 2021Go to article: In DepthGo to article: Skinny labelling of generics: the beginning of the end for this practice?Go to article: Charting the choppy history of ‘magic bullet’ antibody-drug conjugates Go to article: How a sleeping drug awakened a patient with akinetic mutismGo to article: Breast cancer research: addressing the pre-menopausal problemGo to article: Beyond the lung: treating the GI symptoms of Covid-19Go to article: Immortal cells and informed consent: the legacy of Henrietta LacksGo to article: How radiopharmaceuticals are helping fight cancer with Fusion Go to article: Competition heats up as new HIV prevention drug shows promise Go to article: BaxterGo to article: ACG WorldwideGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue